18 May 2017
Here’s the introduction to their piece
While Prime Minister Justin Trudeau spearheads recreational legalization across Canada, the northern nation’s cannabis producers are setting their sights far beyond their own borders and towards the global market.
Currently, there are four giant companies that effectively control the medical marijuana sector in Canada: Cronos Group, Canopy Growth Corporation (which has already collaborated with Snoop Dogg), Aphria, and Tilray. There’s no doubt that each of these cannabis producers will surely direct their attention towards the impending Canadian recreational system, but they’ve also taken advantage of the budding medical marijuana market that has started to develop across the globe.
At the moment, the four producers are exporting their product to a number of foreign countries, including New Zealand, Australia, Chile, Brazil, and Croatia. While the medical cannabis market is just now sprouting up on an international level, some countries are hesitant to start cultivating in their own homeland.
For example, Germany recently approved medical marijuana legislation, but there’s almost still no infrastructure to actually grow cannabis there. Until the proper framework allows local producers to cultivate the crop within their own country, German patients are dependent on exported medication.